Anzeige
Mehr »
Dienstag, 21.10.2025 - Börsentäglich über 12.000 News
Uran-Aktien gehen durch die Decke - diese Aktie könnte der nächste Highflyer sein!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Korea Herald

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14.10.U.S. port fee piles pressure on Hyundai, Kia amid tariff delay
14.10.LG India's blockbuster debut signals new phase of growth
14.10.What Mirae Asset's win over Brookfield means for Korea's property market
14.10.U.S.-China trade clash rattles Korean chipmakers amid rare earth curbs
14.10.HLB Panagene's BioSquare wins FDA nod for rapid strep diagnostic kit
14.10.K-food companies to cater to global palates at APEC summit
14.10.Hyundai, Tesla slash prices as U.S. EV battle intensifies
14.10.Hana Bank launches 'Culture Bank' to support foreign residents
14.10.Kakao Bank's mid-to-low credit loans top W15 tr
14.10.Hanwha plans fireworks, defense forum to coincide with APEC summit
14.10.KT, Palantir chiefs discuss AI expansion in Seoul
14.10.Samsung's chip rebound drives earnings surprise
14.10.Porsche Korea Q3 sales jump 38% on strong EV demand
14.10.Amorepacific, Johns Hopkins unveil skin longevity findings in New York
14.10.Seoul stocks open sharply higher on chip rebound, eased trade war woes
14.10.Samsung Electronics logs largest operating earnings in over 3 yrs in Q3
14.10.Hugel taps ex-AbbVie executive as new global CEO
13.10.The equity market correction - Was that it?
13.10.Seoul stocks snap 3-day rise; won tumbles to 5-month low
13.10.Kospi retreats from record high amid U.S.-China trade jitters
13.10.New housing curbs to come this week as prices remain unrestrained
13.10.In his five years, Chung Euisun has cemented Hyundai's global top-three rank
13.10.Korean pavilion captivates over 3m at Osaka Expo
13.10.Musinsa Tokyo pop-up showcases K-fashion's rising appeal
13.10.Celltrion enters U.S. autoimmune market with Avtozma